What's New

Colorectal cancer is one of the most common cancers in Hong Kong. However, many people delay screening due to concerns about discomfort or risks associated with invasive procedures. The M3CRC™ Non-Invasive Colorectal Cancer Risk Test, developed by The Chinese University of Hong Kong, requires only a small stool sample and no bowel preparation. It accurately analyzes gut bacterial genes to detect polyps and early-stage colorectal cancer, with sensitivity up to 94%, comparable to colonoscopy.

Key Features

• Non-invasive:
  No insertion required, avoiding discomfort and risks

• Patented technology:
  Precisely detects colorectal cancer-associated bacteria (sensitivity up to 94%)

• World’s only test:
  Non-invasive detection of polyps and recurrence (sensitivity over 90%)

• Safe and convenient:
  Requires only a small stool sample submitted to our laboratory

• No bowel preparation:
  Reduces unnecessary procedures and lowers healthcare costs

• Comprehensive report:
  Provides risk assessment plus dietary recommendations to improve gut health

Fees

• $2,990 (Includes one medical consultation)
  (+$200: Option for an additional medical consultation)

Enquiry & Appointment
Tel: 2711 5222